Morgan Stanley Renalytix PLC Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Renalytix PLC stock. As of the latest transaction made, Morgan Stanley holds 2,200 shares of RNLX stock, worth $330. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,200

Previous 6,456 65.92%

Holding current value

$330

Previous $1,000 100.0%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.21 - $0.45 $893 - $1,915	-4,256 Reduced 65.92%	2,200 $0
Q2 2024 Oct 17, 2024	BUY	$0.23 - $0.93 $789 - $3,192	3,433 Added 113.56%	6,456 $1,000
Q2 2024 Aug 14, 2024	BUY	$0.23 - $0.93 $789 - $3,192	3,433 Added 113.56%	6,456 $1,000
Q1 2024 Oct 17, 2024	SELL	$0.26 - $1.47 $892 - $5,046	-3,433 Reduced 53.18%	3,023 $2,000
Q1 2024 Aug 16, 2024	SELL	$0.26 - $1.47 $6,926 - $39,162	-26,641 Reduced 89.81%	3,023 $2,000
Q1 2024 May 15, 2024	SELL	$0.26 - $1.47 $6,926 - $39,162	-26,641 Reduced 89.81%	3,023 $2,000
Q4 2023 Aug 16, 2024	BUY	$0.33 - $1.61 $7,658 - $37,364	23,208 Added 359.48%	29,664 $11,000
Q4 2023 Feb 13, 2024	SELL	$0.33 - $1.61 $1,077 - $5,258	-3,266 Reduced 9.92%	29,664 $11,000
Q3 2023 Nov 15, 2023	SELL	$1.51 - $4.01 $49,879 - $132,462	-33,033 Reduced 50.08%	32,930 $52,000
Q2 2023 Aug 14, 2023	BUY	$2.0 - $2.92 $6,300 - $9,198	3,150 Added 5.01%	65,963 $192,000
Q1 2023 May 15, 2023	BUY	$1.93 - $3.72 $380 - $732	197 Added 0.31%	62,813 $152,000
Q4 2022 Feb 14, 2023	BUY	$1.06 - $2.21 $660 - $1,376	623 Added 1.0%	62,616 $117,000
Q3 2022 Nov 14, 2022	BUY	$1.19 - $2.78 $4,307 - $10,063	3,620 Added 6.2%	61,993 $79,000
Q2 2022 Oct 27, 2022	BUY	$2.45 - $7.81 $102,142 - $325,606	41,691 Added 249.92%	58,373 $143,000
Q2 2022 Aug 15, 2022	BUY	$2.45 - $7.81 $102,142 - $325,606	41,691 Added 249.92%	58,373 $143,000
Q1 2022 Oct 27, 2022	SELL	$5.88 - $15.9 $245,143 - $662,886	-41,691 Reduced 71.42%	16,682 $116,000
Q1 2022 May 13, 2022	BUY	$5.88 - $15.9 $72,735 - $196,683	12,370 Added 286.87%	16,682 $116,000
Q4 2021 Feb 14, 2022	SELL	$13.43 - $27.4 $217,646 - $444,044	-16,206 Reduced 78.98%	4,312 $68,000
Q3 2021 Nov 15, 2021	BUY	$17.91 - $34.78 $367,477 - $713,616	20,518 New	20,518 $411,000

Others Institutions Holding RNLX

# of Institutions

Shares Held

3.91M

Call Options Held

13.7K

Put Options Held

View Full List

About Renalytix plc

Ticker RNLX
Exchange OTC
Sector Healthcare
Industry Health Information Services
Shares Outstandng 37,445,900
Market Cap $5.62M
Description
Renalytix Plc develops artificial intelligence-enabled in vitro diagnostic solutions for kidney diseases. The company offers KidneyIntelX, a diagnostic platform that employs an artificial intelligence-enabled algorithm that combines various data inputs, including validated blood-based biomarkers, inherited genetics and personalized patient data ...

More about RNLX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account